Get the Stockscreener App
35.92
2.25%
0.79
After Hours:
35.92
Spyre Therapeutics Inc Stock (SYRE) Forecast
The Spyre Therapeutics Inc (SYRE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $53.16, representing a +48.00% increase from the current price of $35.92. The highest analyst price target is $58.93, and the lowest is $47.40.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SYRE Price Target
Average 83.58
(+132.70% Upside)
Is Spyre Therapeutics Inc (SYRE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 66.66 | Neutral |
| STOCH(9,6) | 50.27 | Neutral |
| STOCHRSI(14) | 79.73 | Neutral |
| MACD(12,26) | 1.5159 | Buy |
| ADX(14) | 26.48 | Buy |
| William %R | -13.87 | Sell |
| CCI(14) | 153.77 | Buy |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
34.20
Buy
|
34.08
Buy
|
| MA20 |
32.60
Buy
|
32.88
Buy
|
| MA50 |
30.14
Buy
|
30.93
Buy
|
| MA100 |
28.52
Buy
|
29.97
Buy
|
| MA200 |
30.89
Buy
|
29.52
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SYRE could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 1 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on SYRE, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 66.66 indicates that SYRE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 50.27 indicates that SYRE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.73 indicates that SYRE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.48 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 153.77 indicates that SYRE is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SYRE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Spyre Therapeutics Inc financial reports and earnings history, Spyre Therapeutics Inc (SYRE) stock could reach $333.03 by 2030, $642.45 by 2040 and $1,244.69 by 2050. See the projected annual prices until 2050 of the Spyre Therapeutics Inc stock below:
- Spyre Therapeutics Inc (SYRE) is expected to reach an average price of $550.20 in 2035, with a high prediction of $555.27 and a low estimate of $502.17. This indicates an $1,432% rise from the last recorded price of $35.92.
- Spyre Therapeutics Inc (SYRE) stock is projected to chart a bullish course in 2040, with an average price target of $639.77, representing an $1,681% surge from its current level. The forecast ranges from a conservative $591.47 to a sky-high $642.45.
- Our analysts predict Spyre Therapeutics Inc (SYRE) to jump 1,743% by 2045, soaring from $634.03 to an average price of $662.02, potentially reaching $1,120.34. While $634.03 is the low estimate, the potential upside is significant.
- Spyre Therapeutics Inc (SYRE) stock is expected to climb by 2050, reaching an average of $1,237.92, a $3,346% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,244.69 and $1,156.32, respectively, highlighting the market's uncertainty.
Spyre Therapeutics Inc Stock (SYRE) Year by Year Forecast
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2024
Our forecast for SYRE stock price in 2024 now indicates an average price target of $45.22 with a high forecast of $71.90 and a low forecast of $18.54. The average prediction reflects an increase of +25.90% from the last recorded price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $58.17 | $47.40 | $58.93 | +61.94% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2025
Spyre Therapeutics Inc Stock (SYRE) is expected to reach an average price of $87.91 in 2025, with a high prediction of $119.77 and a low estimate of $56.05. This indicates an +144.74% rise from the last recorded price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $66.26 | $57.17 | $68.19 | +84.47% |
| February, 2025 | $71.64 | $63.35 | $73.00 | +99.43% |
| March, 2025 | $89.07 | $73.59 | $95.84 | +147.96% |
| April, 2025 | $86.02 | $83.28 | $91.79 | +139.48% |
| May, 2025 | $66.59 | $56.05 | $90.03 | +85.38% |
| June, 2025 | $74.04 | $63.98 | $74.52 | +106.12% |
| July, 2025 | $85.32 | $72.44 | $88.00 | +137.52% |
| August, 2025 | $88.50 | $84.99 | $88.65 | +146.37% |
| September, 2025 | $115.80 | $89.34 | $118.04 | +222.37% |
| October, 2025 | $109.72 | $108.13 | $119.77 | +205.47% |
| November, 2025 | $79.50 | $71.26 | $116.72 | +121.33% |
| December, 2025 | $91.54 | $78.92 | $92.02 | +154.85% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2026
The predicted value for Spyre Therapeutics Inc (SYRE) in 2026 is set at an average of $128.30. Estimates vary from a peak of $170.13 to a trough of $86.47, indicating an +257.19% surge from the present price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $104.87 | $90.40 | $106.03 | +191.96% |
| February, 2026 | $107.94 | $105.05 | $108.96 | +200.49% |
| March, 2026 | $129.99 | $106.62 | $133.15 | +261.90% |
| April, 2026 | $138.74 | $129.83 | $143.71 | +286.24% |
| May, 2026 | $139.23 | $135.05 | $143.41 | +287.61% |
| June, 2026 | $98.44 | $86.47 | $104.23 | +174.05% |
| July, 2026 | $118.54 | $100.60 | $119.22 | +230.00% |
| August, 2026 | $127.55 | $120.93 | $129.68 | +255.10% |
| September, 2026 | $153.01 | $127.63 | $156.17 | +325.98% |
| October, 2026 | $160.44 | $153.31 | $167.64 | +346.67% |
| November, 2026 | $166.48 | $160.83 | $170.10 | +363.47% |
| December, 2026 | $115.03 | $101.68 | $170.13 | +220.23% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Spyre Therapeutics Inc (SYRE) is $170.66, with a high forecast of $224.43 and a low forecast of $116.89. This indicates an +375.11% increase from the last price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $131.95 | $117.65 | $136.36 | +267.33% |
| February, 2027 | $147.31 | $133.80 | $148.02 | +310.09% |
| March, 2027 | $165.24 | $147.88 | $168.33 | +360.03% |
| April, 2027 | $184.29 | $168.99 | $191.58 | +413.06% |
| May, 2027 | $190.94 | $182.69 | $193.26 | +431.58% |
| June, 2027 | $132.51 | $116.89 | $197.28 | +268.90% |
| July, 2027 | $148.00 | $130.33 | $148.76 | +312.01% |
| August, 2027 | $164.52 | $149.29 | $167.20 | +358.03% |
| September, 2027 | $182.12 | $166.39 | $183.48 | +407.03% |
| October, 2027 | $208.74 | $186.38 | $215.51 | +481.13% |
| November, 2027 | $212.81 | $207.15 | $218.94 | +492.45% |
| December, 2027 | $144.93 | $132.10 | $224.43 | +303.49% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2028
In 2028, Spyre Therapeutics Inc (SYRE) is projected to reach an average price of $212.40, with a high projection of $278.73 and a low estimate of $146.07. This indicates an +491.31% rise from the last price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $161.57 | $146.07 | $162.05 | +349.80% |
| February, 2028 | $182.24 | $162.26 | $183.40 | +407.35% |
| March, 2028 | $196.69 | $184.25 | $196.84 | +447.57% |
| April, 2028 | $233.17 | $199.83 | $235.41 | +549.14% |
| May, 2028 | $238.58 | $228.89 | $244.71 | +564.20% |
| June, 2028 | $155.55 | $147.31 | $251.58 | +333.05% |
| July, 2028 | $171.59 | $157.27 | $171.82 | +377.70% |
| August, 2028 | $201.58 | $175.38 | $202.74 | +461.20% |
| September, 2028 | $213.83 | $204.06 | $214.61 | +495.31% |
| October, 2028 | $245.07 | $214.82 | $248.23 | +582.28% |
| November, 2028 | $265.30 | $247.21 | $268.64 | +638.58% |
| December, 2028 | $271.32 | $263.91 | $278.73 | +655.34% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2029
The 2029 price forecast for Spyre Therapeutics Inc Stock (SYRE) is $243.47 on average, with a high prediction of $324.41 and a low estimate of $162.52. This represents an +577.80% increase from the previous price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $188.64 | $162.52 | $188.86 | +425.16% |
| February, 2029 | $212.95 | $192.89 | $213.64 | +492.86% |
| March, 2029 | $231.15 | $217.65 | $233.28 | +543.52% |
| April, 2029 | $255.47 | $233.52 | $258.56 | +611.22% |
| May, 2029 | $284.71 | $261.06 | $288.22 | +692.62% |
| June, 2029 | $299.93 | $288.75 | $303.55 | +734.98% |
| July, 2029 | $197.02 | $177.73 | $305.88 | +448.50% |
| August, 2029 | $224.07 | $196.68 | $228.48 | +523.79% |
| September, 2029 | $248.61 | $228.22 | $249.33 | +592.12% |
| October, 2029 | $278.03 | $251.48 | $281.12 | +674.01% |
| November, 2029 | $306.26 | $284.07 | $311.33 | +752.62% |
| December, 2029 | $322.09 | $306.95 | $324.41 | +796.70% |
Spyre Therapeutics Inc Stock (SYRE) Price Forecast for 2030
Spyre Therapeutics Inc Stock (SYRE) is expected to reach an average price of $281.42 in 2030, with a high forecast of $369.89 and a low forecast of $192.94. This signifies an +683.45% surge from the last price of $35.92.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $213.15 | $192.94 | $333.03 | +493.40% |
| February, 2030 | $237.82 | $213.27 | $238.58 | +562.09% |
| March, 2030 | $263.53 | $241.41 | $266.21 | +633.66% |
| April, 2030 | $283.24 | $267.69 | $283.40 | +688.54% |
| May, 2030 | $328.41 | $288.22 | $335.18 | +814.29% |
| June, 2030 | $341.66 | $329.11 | $347.79 | +851.18% |
| July, 2030 | $223.28 | $208.15 | $360.17 | +521.60% |
| August, 2030 | $249.10 | $226.71 | $249.58 | +593.48% |
| September, 2030 | $278.95 | $252.09 | $280.11 | +676.60% |
| October, 2030 | $304.88 | $283.26 | $305.04 | +748.78% |
| November, 2030 | $350.55 | $310.32 | $352.79 | +875.91% |
| December, 2030 | $366.55 | $348.56 | $369.89 | +920.45% |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):